Press Release

• 31 March 2008Landmark trial ONTARGET® proves telmisartan is as protective as ramipril and better tolerated in a broad high-risk cardiovascular population.
• 10 March 2004Baseline data from landmark cardiovascular protection trial, ONTARGET®, reveal a dramatic shift in treatment patterns.
• 18 June 2003First phase of ONTARGET®/TRANSCEND™ cardiovascular protection megatrial completed - All patients enrolled ahead of target
• press release archive

Documents

• Backgrounder: Cardiovascular Disease - PDF (192 KB)
• Backgrounder: The ONTARGET® Trial Programme - PDF (171 KB)
• Annual Report 2007 (Chapter: Serving patients - Human Pharmaceuticals) - PDF (4.9 MB)

Video

• Broadcast media video footage - ONTARGET®

Related Links

• Focus on Clincal Research - interactive animation
• Landmark trials
• Research & Development
• Trial results press briefing (1 April 2008)

External Links

• Boehringer Ingelheim Global Clinical Trials website
• IFPMA Clinical Trials website